Health Care Down, But not by Much, on Defensive Bias - Health Care Roundup

Health-care companies experienced a slight decline, less than the overall market, as investors shifted to defensive sectors amid geopolitical concerns. Moderna and Merck reported promising five-year Phase 2b trial data for their cancer vaccine, showing reduced relapse or death risk for melanoma patients. Public skepticism surrounds Robert F. Kennedy Jr.'s vaccine policy reform efforts, with a Wall Street Journal poll indicating half of U.S. voters feel the Trump administration has undermined confidence in federal vaccine guidance. Novo Nordisk is advertising Ozempic with a nod to Apple's "Get a Mac" campaign to differentiate it from other diabetes drugs.